Insider Transactions in Q4 2022 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2022
|
Andrew Booth Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
50,000
-26.53%
|
-
|
|
Dec 20
2022
|
Andrew Booth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+20.96%
|
$0
$0.19 P/Share
|
|
Dec 16
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
85,102
+0.15%
|
$851,020
$10.1 P/Share
|
|
Nov 18
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+11.11%
|
$112,250
$2.7 P/Share
|
|
Oct 31
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
70,000
-0.13%
|
-
|